ITGAM and neoplasm: Research indicates that blocking chemotaxis not only suppresses tumor-induced osteomyelitis in metastatic castration-resistant prostate cancer (CRPC) patient subgroups, but also lowers circulating neutrophils and reduces intratumoral infiltration of CD11b+HLA-DRloCD15+CD14−myeloid cells.